Source: https://sharpbrains.com/blog/2020/09/08/study-finds-surprising-correlation-between-states-elevation-and-adhd-prevalence/
Who would have thought that children living at higher altitudes have lower risk of developing ADHD than peers at lower elevation levels? As the research described below suggests, however, this may be the case.
The impetus for this study is the well-documented regional variation in the prevalence of ADHD in youth. For example, national data for the years 2007–2009 indicate that ADHD prevalence rates were approximately 10% in the south and midwest but only 5% in the western US. How can such substantial regional variation be explained?
The Study:
The authors of a recently published study, Association between altitude and regional variation of ADHD in youth, suggest th…
Source: https://sharpbrains.com/blog/2020/09/08/study-finds-surprising-correlation-between-states-elevation-and-adhd-prevalence/
Who would have thought that children living at higher altitudes have lower risk of developing ADHD than peers at lower elevation levels? As the research described below suggests, however, this may be the case.
The impetus for this study is the well-documented regional variation in the prevalence of ADHD in youth. For example, national data for the years 2007–2009 indicate that ADHD prevalence rates were approximately 10% in the south and midwest but only 5% in the western US. How can such substantial regional variation be explained?
The Study:
The authors of a recently published study, Association between altitude and regional variation of ADHD in youth, suggest th…
Source: https://sharpbrains.com/blog/2020/09/11/anticholinergic-drugs-found-to-significantly-increase-risk-of-cognitive-decline-especially-among-those-with-alzheimers-disease-biomarkers-or-genetic-predisposition/
Common Class of Drugs Linked to Increased Risk of Alzheimer’s Disease (UC San Diego release):
A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adults at greater risk for Alzheimer’s disease (AD) … cognitively normal study participants who were taking at least one anticholinergic drug at baseline were 47 percent more likely to develop mild cognitive impairment (MCI), often a pre…
Source: https://sharpbrains.com/blog/2020/09/11/anticholinergic-drugs-found-to-significantly-increase-risk-of-cognitive-decline-especially-among-those-with-alzheimers-disease-biomarkers-or-genetic-predisposition/
Common Class of Drugs Linked to Increased Risk of Alzheimer’s Disease (UC San Diego release):
A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adults at greater risk for Alzheimer’s disease (AD) … cognitively normal study participants who were taking at least one anticholinergic drug at baseline were 47 percent more likely to develop mild cognitive impairment (MCI), often a pre…
Source: http://www.brainhealtheducation.org/statement-on-bleeding-concerns-a-comparative-overview-of-prescription-omega-3-fatty-acid-products/
Drug Interactions The following products have been investigated in clinical drug–drug interaction studies with the RxOM3FAs [prescription omega-3 fatty acids]: warfarin (Vascepa, Epanova); omeprazole (Vascepa); rosiglitazone (Vascepa); atorvastatin (Lovaza, Vascepa, Omtryg); rosuvastatin (Lovaza, Omtryg); and simvastatin (Lovaza, Omtryg, Epanova).1–4,23–28 No drug–drug interactions were observed. The package inserts for all RxOM3FAs note that patients who are receiving
Read More…
…
Source: http://www.brainhealtheducation.org/statement-on-bleeding-concerns-a-comparative-overview-of-prescription-omega-3-fatty-acid-products/
Drug Interactions The following products have been investigated in clinical drug–drug interaction studies with the RxOM3FAs [prescription omega-3 fatty acids]: warfarin (Vascepa, Epanova); omeprazole (Vascepa); rosiglitazone (Vascepa); atorvastatin (Lovaza, Vascepa, Omtryg); rosuvastatin (Lovaza, Omtryg); and simvastatin (Lovaza, Omtryg, Epanova).1–4,23–28 No drug–drug interactions were observed. The package inserts for all RxOM3FAs note that patients who are receiving
Read More…
…
Source: https://www.aarp.org/health/conditions-treatments/info-2020/obesity-complicates-coronavirus.html
Excess weight can complicate breathing and impact the body’s immune response … Getty Images … Physicians and researchers are noting a troubling trend among the more than 380,000 Americans who h……
Source: https://www.aarp.org/health/conditions-treatments/info-2020/obesity-complicates-coronavirus.html
Excess weight can complicate breathing and impact the body’s immune response … Getty Images … Physicians and researchers are noting a troubling trend among the more than 380,000 Americans who h……
Source: https://www.webmd.com/lung/news/20200911/blood-pressure-meds-can-affect-covid-19-care?src=RSS_PUBLIC
People with high blood pressure tend to fare worse when infected with COVID-19, and the chronic condition can complicate their treatment in unexpected ways, new research shows.
…
Source: https://www.webmd.com/lung/news/20200911/blood-pressure-meds-can-affect-covid-19-care?src=RSS_PUBLIC
People with high blood pressure tend to fare worse when infected with COVID-19, and the chronic condition can complicate their treatment in unexpected ways, new research shows.
…
Source: https://www.aarp.org/health/conditions-treatments/info-2020/computer-glasses-blue-light-protection.html
What to do (or not to do) about digital eyestrain … Getty Images … As the coronavirus pandemic has driven many of us online for work, meetings and even socializing, sales of computer glasses ar……
Source: https://www.aarp.org/health/conditions-treatments/info-2020/computer-glasses-blue-light-protection.html
What to do (or not to do) about digital eyestrain … Getty Images … As the coronavirus pandemic has driven many of us online for work, meetings and even socializing, sales of computer glasses ar……
Source: http://www.brainhealtheducation.org/concussion-discovery-reveals-dire-unknown-effect-of-even-mild-brain-injuries/
Even mild concussions cause severe and long-lasting impairments in the brain’s ability to clean itself of toxins, and this may seed it for Alzheimer’s disease, dementia and other neurodegenerative problems, new research from the University of Virginia School of Medicine reveals. The findings help explain why TBI is so harmful and why it can have
Read More…
…
Source: http://www.brainhealtheducation.org/concussion-discovery-reveals-dire-unknown-effect-of-even-mild-brain-injuries/
Even mild concussions cause severe and long-lasting impairments in the brain’s ability to clean itself of toxins, and this may seed it for Alzheimer’s disease, dementia and other neurodegenerative problems, new research from the University of Virginia School of Medicine reveals. The findings help explain why TBI is so harmful and why it can have
Read More…
…
Source: https://www.aarp.org/health/conditions-treatments/info-2020/understanding-coronavirus-test-results.html
A negative coronavirus test doesn’t necessarily mean you’re in the clear for COVID-19. … It turns out timing has a lot to do with the accuracy of test results. … In a seven-study analysis, a te……
Source: https://www.aarp.org/health/conditions-treatments/info-2020/understanding-coronavirus-test-results.html
A negative coronavirus test doesn’t necessarily mean you’re in the clear for COVID-19. … It turns out timing has a lot to do with the accuracy of test results. … In a seven-study analysis, a te……
Source: https://brainhealth.utdallas.edu/tag-release/
DALLAS (September 10, 2020) – Think Ahead Group (TAG), the young professionals donor organization of the Center for BrainHealth® at The University of Texas at Dallas, recently announced its board members and co-leaders for the 2020-2021 season. In taking up the cause of BrainHealth, TAG members are energized and motivated to support cognitive neuroscience research and to serve as advocates for the benefits of taking a proactive approach to the brain’s health and performance from a young age.
Since its inception in 2009, TAG has raised more than $320,000 to support the Center’s leading-edge research into strategies and technologies for people to leverage the brain’s amazing adaptability in the face of challenges such as autism, chemo brain, depression, traumatic brain injury, chronic stress and Alzheimer’s.
Continuing in their role as co-presidents for the second year running are Kristen Carter and Kendal Dodge, who have been members since 2014.<im…
Source: https://brainhealth.utdallas.edu/tag-release/
DALLAS (September 10, 2020) – Think Ahead Group (TAG), the young professionals donor organization of the Center for BrainHealth® at The University of Texas at Dallas, recently announced its board members and co-leaders for the 2020-2021 season. In taking up the cause of BrainHealth, TAG members are energized and motivated to support cognitive neuroscience research and to serve as advocates for the benefits of taking a proactive approach to the brain’s health and performance from a young age.
Since its inception in 2009, TAG has raised more than $320,000 to support the Center’s leading-edge research into strategies and technologies for people to leverage the brain’s amazing adaptability in the face of challenges such as autism, chemo brain, depression, traumatic brain injury, chronic stress and Alzheimer’s.
Continuing in their role as co-presidents for the second year running are Kristen Carter and Kendal Dodge, who have been members since 2014.<im…
Source: http://www.brainhealtheducation.org/failure-of-omega-3s-to-prevent-slow-alzheimers-explained/
Much higher doses of docosahexaenoic acid (DHA) than initially thought may be required to effectively fight Alzheimer’s disease (AD), new research suggests. In results that could explain why the omega-3 fatty acid has failed to prevent AD or slow its progression, investigators found that among individuals who took omega-3 supplements, DHA blood plasma levels were high, but
Read More…
…
Source: http://www.brainhealtheducation.org/failure-of-omega-3s-to-prevent-slow-alzheimers-explained/
Much higher doses of docosahexaenoic acid (DHA) than initially thought may be required to effectively fight Alzheimer’s disease (AD), new research suggests. In results that could explain why the omega-3 fatty acid has failed to prevent AD or slow its progression, investigators found that among individuals who took omega-3 supplements, DHA blood plasma levels were high, but
Read More…
…